These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

696 related articles for article (PubMed ID: 23090118)

  • 1. Tryptophan catabolism in cancer: beyond IDO and tryptophan depletion.
    Platten M; Wick W; Van den Eynde BJ
    Cancer Res; 2012 Nov; 72(21):5435-40. PubMed ID: 23090118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of tryptophan metabolism in cancers and therapeutic implications.
    Liu XH; Zhai XY
    Biochimie; 2021 Mar; 182():131-139. PubMed ID: 33460767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tryptophan Catabolism and Cancer Immunotherapy Targeting IDO Mediated Immune Suppression.
    Amobi A; Qian F; Lugade AA; Odunsi K
    Adv Exp Med Biol; 2017; 1036():129-144. PubMed ID: 29275469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor immune escape mediated by indoleamine 2,3-dioxygenase.
    Zamanakou M; Germenis AE; Karanikas V
    Immunol Lett; 2007 Aug; 111(2):69-75. PubMed ID: 17644189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Shaping the glioma immune microenvironment through tryptophan metabolism.
    Platten M; Weller M; Wick W
    CNS Oncol; 2012 Sep; 1(1):99-106. PubMed ID: 25054303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IDO induces expression of a novel tryptophan transporter in mouse and human tumor cells.
    Silk JD; Lakhal S; Laynes R; Vallius L; Karydis I; Marcea C; Boyd CA; Cerundolo V
    J Immunol; 2011 Aug; 187(4):1617-25. PubMed ID: 21742973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implications of IFN-gamma-mediated tryptophan catabolism on solid organ transplantation.
    Brandacher G; Margreiter R; Fuchs D
    Curr Drug Metab; 2007 Apr; 8(3):273-82. PubMed ID: 17430115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Indoleamine 2,3-Dioxygenase Activity-Induced Acceleration of Tumor Growth, and Protein Kinases-Related Novel Therapeutics Regimens.
    Engin AB; Engin A
    Adv Exp Med Biol; 2021; 1275():339-356. PubMed ID: 33539022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydroxyamidine inhibitors of indoleamine-2,3-dioxygenase potently suppress systemic tryptophan catabolism and the growth of IDO-expressing tumors.
    Koblish HK; Hansbury MJ; Bowman KJ; Yang G; Neilan CL; Haley PJ; Burn TC; Waeltz P; Sparks RB; Yue EW; Combs AP; Scherle PA; Vaddi K; Fridman JS
    Mol Cancer Ther; 2010 Feb; 9(2):489-98. PubMed ID: 20124451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reimagining IDO Pathway Inhibition in Cancer Immunotherapy via Downstream Focus on the Tryptophan-Kynurenine-Aryl Hydrocarbon Axis.
    Labadie BW; Bao R; Luke JJ
    Clin Cancer Res; 2019 Mar; 25(5):1462-1471. PubMed ID: 30377198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Indoleamine 2,3-dioxygenase: is it an immune suppressor?
    Soliman H; Mediavilla-Varela M; Antonia S
    Cancer J; 2010; 16(4):354-9. PubMed ID: 20693847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The new '5-HT' hypothesis of depression: cell-mediated immune activation induces indoleamine 2,3-dioxygenase, which leads to lower plasma tryptophan and an increased synthesis of detrimental tryptophan catabolites (TRYCATs), both of which contribute to the onset of depression.
    Maes M; Leonard BE; Myint AM; Kubera M; Verkerk R
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Apr; 35(3):702-21. PubMed ID: 21185346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of indoleamine 2,3-dioxygenase in antimicrobial defence and immuno-regulation: tryptophan depletion versus production of toxic kynurenines.
    MacKenzie CR; Heseler K; Müller A; Däubener W
    Curr Drug Metab; 2007 Apr; 8(3):237-44. PubMed ID: 17430112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Canine mast cell tumour cells regulate tryptophan catabolism via the expression of indoleamine 2,3-dioxygenase.
    Matsuda A; Hata A; Tanaka A; Matsuda H
    Res Vet Sci; 2021 Jul; 137():159-162. PubMed ID: 33984619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of indoleamine 2,3-dioxygenase in testicular immune-privilege.
    Gualdoni GS; Jacobo PV; Sobarzo CM; Pérez CV; Matzkin ME; Höcht C; Frungieri MB; Hill M; Anegon I; Lustig L; Guazzone VA
    Sci Rep; 2019 Nov; 9(1):15919. PubMed ID: 31685866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of indoleamine 2,3-dioxygenase-mediated tryptophan catabolism accelerates collagen-induced arthritis in mice.
    Szántó S; Koreny T; Mikecz K; Glant TT; Szekanecz Z; Varga J
    Arthritis Res Ther; 2007; 9(3):R50. PubMed ID: 17511858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunosuppressive Amino-Acid Catabolizing Enzymes in Multiple Sclerosis.
    Correale J
    Front Immunol; 2020; 11():600428. PubMed ID: 33552055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of water-immersion restraint stress on tryptophan catabolism through the kynurenine pathway in rat tissues.
    Ohta Y; Kubo H; Yashiro K; Ohashi K; Tsuzuki Y; Wada N; Yamamoto Y; Saito K
    J Physiol Sci; 2017 May; 67(3):361-372. PubMed ID: 27364617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malaria parasite induces tryptophan-related immune suppression in mice.
    Tetsutani K; To H; Torii M; Hisaeda H; Himeno K
    Parasitology; 2007 Jul; 134(Pt 7):923-30. PubMed ID: 17316473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficient tryptophan-catabolizing activity is consistently conserved through evolution of TDO enzymes, but not IDO enzymes.
    Yuasa HJ; Ball HJ
    J Exp Zool B Mol Dev Evol; 2015 Mar; 324(2):128-40. PubMed ID: 25702628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.